Dr. Berman speaks at 1st Annual ARP Seminar

JUNE 5-6 2015 Dr. Berman accepted a position on the Advisory Committee for the Academy of Regenerative Practices (ARP), and presented the following lecture at their first annual conference in Fort Lauderdale, Florida. Mark Berman, MD, FACS presents: “Controlled Studies”  A discussion of in-clinic cellular treatments and current empirical findings.  Results are largely positive, and dependent upon…

Details

Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. The study involved 21 people whose disability due to MS had…

Details

Cell Surgical Network performs their first Ophthalmology deployment for Leber’s Optic Neuropathy

Board Certified Ophthalmologist Dr. David Milstein and CSN co-founder Dr. Elliot Lander. Cell Surgical Network performed their first Stromal Vascular Fraction (SVF) retrobulbar deployment for Leber’s optic neuropathy in our Rancho Mirage office. The patient is doing well and we are excited to see the long term benefits of CSN’s new Institutional Review Board (IRB) approved…

Details